AbbVie shares jump as results beat expectations despite blockbuster Humira’s declining sales
July 27, 2023 at 11:15 AM EDT
Newer immunology drugs Skyrizi and Rinvoq boost sales in second quarter.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
